Trial record 2 of 57 for: "Central serous chorioretinopathy"
Methotrexate for Central Serous Chorioretinopathy Treatment Trial (MTX4CSC)
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT01633983|
Recruitment Status : Unknown
Verified July 2012 by Edward Averbukh, Hadassah Medical Organization.
Recruitment status was: Not yet recruiting
First Posted : July 6, 2012
Last Update Posted : July 20, 2012
Information provided by (Responsible Party):
Edward Averbukh, Hadassah Medical Organization
No Study Results Posted on ClinicalTrials.gov for this Study
|Recruitment Status :||Unknown|
|Estimated Primary Completion Date :||July 2014|
|Estimated Study Completion Date :||July 2015|